wildaman,have a read of the interview with ceo http://www.businessspectator.com.au/bs.nsf/Article/KGB-SPECIAL-Brett-Godfrey-pd20090730-UEUN4?OpenDocument
RBL Recce Pharmaceuticals advances global reach with Indonesia’s approval for Phase 3 Diabetic Foot Infection Trial